Published in Br Heart J on March 01, 1991
Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J Clin Invest (1976) 3.42
Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation (1984) 2.57
Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res (1985) 2.23
Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res (1989) 2.14
Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet (1988) 1.98
Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study. Circulation (1984) 1.82
Cellular mechanisms of myocardial infarct expansion. Circulation (1988) 1.77
Determination of left ventricular end-systolic pressure-volume relationships by the conductance (volume) catheter technique. Circulation (1986) 1.47
The left ventricular dP/dtmax-end-diastolic volume relation in closed-chest dogs. Circ Res (1985) 1.45
Use of a conductance (volume) catheter and transient inferior vena caval occlusion for rapid determination of pressure-volume relationships in man. Cathet Cardiovasc Diagn (1988) 1.21
Continuous stroke volume and cardiac output from intra-ventricular dimensions obtained with impedance catheter. Cardiovasc Res (1981) 1.16
Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure. J Am Coll Cardiol (1985) 1.09
Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure. Br Heart J (1983) 1.07
Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure. Circulation (1984) 1.03
Importance of venodilatation in prevention of left ventricular dilatation after chronic large myocardial infarction in rats: a comparison of captopril and hydralazine. Circ Res (1989) 0.99
Prognostic value of exercise electrocardiogram in men at high risk of future coronary heart disease: Multiple Risk Factor Intervention Trial experience. J Am Coll Cardiol (1986) 0.96
MYOCARDIAL ACTIONS OF ANGIOTENSIN. Circ Res (1964) 0.96
Mechanism for the postive inotropic effect of angiotensin II on isolated cardiac muscle. Circ Res (1976) 0.95
Positive chronotropic and inotropic effects of angiotensin II in the dog heart. Eur J Pharmacol (1978) 0.93
Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart. Eur J Pharmacol (1985) 0.93
Effectiveness of converting enzyme inhibition (enalapril) for mild congestive heart failure. Am J Cardiol (1986) 0.87
Computation of the input impedances of a catheter for cardiac volumetry. IEEE Trans Biomed Eng (1984) 0.82
Enalapril (MK-421), a new angiotensin-converting enzyme inhibitor. Acute and chronic effects in heart failure. Chest (1983) 0.79
The athlete's heart. A meta-analysis of cardiac structure and function. Circulation (2000) 4.04
Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet (1998) 3.71
Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. J Am Coll Cardiol (1986) 2.58
Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation (1984) 2.57
Opioid overdose in a patient using a fentanyl patch during treatment with a warming blanket. Anesth Analg (2001) 2.39
No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Cardiol (2001) 2.31
Mechanisms of angina pectoris in syndrome X assessed by myocardial perfusion dynamics and heart rate variability. Eur Heart J (1995) 2.21
[Thyroid function, activities of daily living and survival in extreme old age: the 'Leiden 85-plus Study']. Ned Tijdschr Geneeskd (2006) 2.11
Beneficial effect of enalapril on left ventricular remodelling in patients with a severe residual stenosis after acute anterior wall infarction. Eur Heart J (1997) 2.06
Quantification of pulmonary and systemic blood flow by magnetic resonance velocity mapping in the assessment of atrial-level shunts. Int J Card Imaging (1996) 2.04
Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc Res (2000) 2.00
Antithrombotic therapy in patients undergoing TAVI: an overview of Dutch hospitals. Neth Heart J (2014) 1.85
Gender differences in diagnosis and treatment of coronary artery disease from 1981 to 1997. No evidence for the Yentl syndrome. Eur Heart J (2000) 1.81
Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial. N Engl J Med (1985) 1.74
[The practice guideline 'Heart failure' (first revision) from the Dutch College of General Practitioners; a response from the perspective of cardiology]. Ned Tijdschr Geneeskd (2005) 1.71
C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons. Arterioscler Thromb Vasc Biol (2000) 1.70
No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice. Arterioscler Thromb Vasc Biol (2005) 1.70
Left ventricular measurements with cine and spin-echo MR imaging: a study of reproducibility with variance component analysis. Radiology (1993) 1.63
Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect. Pediatrics (1989) 1.63
Radionuclide techniques for the assessment of myocardial viability and hibernation. Heart (2004) 1.62
Survival and complication free survival in Marfan's syndrome: implications of current guidelines. Heart (1999) 1.62
Paradoxical pressor effects of beta-blockers in standing elderly patients with mild hypertension: a beneficial side effect. Circulation (2002) 1.60
Non-compaction cardiomyopathy-echocardiographic diagnosis. Eur J Echocardiogr (2002) 1.59
Reduced disorderliness of growth hormone release in biochemically inactive acromegaly after pituitary surgery. Eur J Endocrinol (1998) 1.56
Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arterioscler Thromb Vasc Biol (2005) 1.56
Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation (1993) 1.55
Effect of intramyocardial bone marrow cell injection on left ventricular dyssynchrony and global strain. Heart (2008) 1.55
Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome. Am J Cardiol (1998) 1.55
Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. Eur Heart J (1992) 1.55
A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: evidence for publication bias. Am Heart J (2002) 1.53
80 years of Netherlands Society of Cardiology. Neth Heart J (2014) 1.53
Immediate thallium-201 reinjection following stress imaging: a time-saving approach for detection of myocardial viability. J Nucl Med (1993) 1.52
A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. J Clin Endocrinol Metab (2001) 1.51
Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia. J Hypertens (2001) 1.51
Persistent precordial "hyperacute" T-waves signify proximal left anterior descending artery occlusion. Heart (2009) 1.51
Assessing right ventricular function: the role of echocardiography and complementary technologies. Heart (2006) 1.50
Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol (2000) 1.48
Accuracy and precision of quantitative digital coronary arteriography: observer-, short-, and medium-term variabilities. Cathet Cardiovasc Diagn (1993) 1.48
Altered neuroregulation of GH secretion in viscerally obese premenopausal women. J Clin Endocrinol Metab (2001) 1.45
The additive value of gated SPET myocardial perfusion imaging in patients with known and suspected coronary artery disease. Nucl Med Commun (2001) 1.43
Six months of recombinant human GH therapy in patients with ischemic cardiac failure does not influence left ventricular function and mass. J Clin Endocrinol Metab (2001) 1.43
Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardium-derived cells into the infarcted mouse heart. Circulation (2007) 1.42
Biophysical properties of the normal-sized aorta in patients with Marfan syndrome: evaluation with MR flow mapping. Radiology (2001) 1.42
Evaluation of a new transcardiac conductance method for continuous on-line measurement of left ventricular volume. Crit Care Med (2000) 1.41
[Screening of asymptomatic individuals for coronary disease using CT-calcium measurement in the coronary arteries]. Ned Tijdschr Geneeskd (2006) 1.40
Acute and short-term effects of partial left ventriculectomy in dilated cardiomyopathy: assessment by pressure-volume loops. J Am Coll Cardiol (2000) 1.40
[Intramyocardial injection of autologous bone-marrow stem cells in a 74-year-old man with untreatable angina pectoris and demonstrated myocardial ischaemia]. Ned Tijdschr Geneeskd (2006) 1.40
Raman microspectroscopy of human coronary atherosclerosis: biochemical assessment of cellular and extracellular morphologic structures in situ. Cardiovasc Pathol (2001) 1.40
Comparison between manual and semiautomated analysis of left ventricular volume parameters from short-axis MR images. J Comput Assist Tomogr (1997) 1.39
Micro stent, quantitative coronary angiography, and procedural results. Cathet Cardiovasc Diagn (1996) 1.39
Acute elevation of coronary venous pressure does not affect left ventricular contractility in the normal and stressed swine heart: implications for the Fontan operation. J Thorac Cardiovasc Surg (1997) 1.39
Evaluation of the incremental diagnostic value and impact on patient treatment of thallium scintigraphy. J Nucl Med (1992) 1.39
Development of an MRI-compatible catheter for pacing the heart: initial in vitro and in vivo results. J Magn Reson Imaging (1997) 1.39
Evaluation of the long-term functional outcome assessed by myocardial perfusion scintigraphy following excimer laser angioplasty compared to balloon angioplasty in longer coronary lesions. Int J Card Imaging (2000) 1.39
[The immune system and Alzheimer's disease]. Tijdschr Psychiatr (2011) 1.38
Automated measurement of volume flow in the ascending aorta using MR velocity maps: evaluation of inter- and intraobserver variability in healthy volunteers. J Comput Assist Tomogr (1998) 1.37
Value of fast gradient echo magnetic resonance angiography as an adjunct to coronary arteriography in detecting and confirming the course of clinically significant coronary artery anomalies. Am J Cardiol (1997) 1.33
Effect of spinal cord stimulation on myocardial blood flow assessed by positron emission tomography in patients with refractory angina pectoris. Am J Cardiol (1996) 1.33
cGMP and nitric oxide modulate thrombin-induced endothelial permeability. Regulation via different pathways in human aortic and umbilical vein endothelial cells. Circ Res (1995) 1.33
Postoperative pulmonary flow dynamics after Fontan surgery: assessment with nuclear magnetic resonance velocity mapping. J Am Coll Cardiol (1993) 1.32
Functional and metabolic evaluation of the athlete's heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy. Circulation (1998) 1.31
Inflammation and stroke: the Leiden 85-Plus Study . Stroke (2002) 1.29
Left ventricular function: correlation of quantitative gated SPECT and MR imaging over a wide range of values. Radiology (2000) 1.28
Magnetic resonance measurement of velocity and flow: technique, validation, and cardiovascular applications. Am Heart J (1993) 1.27
Dynamic myocardial scintigraphy with 123I-labeled free fatty acids in patients with myocardial infarction. Eur J Nucl Med (1981) 1.27
Comparison of ultrafast dipyridamole magnetic resonance imaging with dipyridamole SestaMIBI SPECT for detection of perfusion abnormalities in patients with one-vessel coronary artery disease: assessment by quantitative model fitting. Magn Reson Med (1996) 1.26
Effects of early intracoronary streptokinase on infarct size estimated from cumulative enzyme release and on enzyme release rate: a randomized trial of 533 patients with acute myocardial infarction. Am Heart J (1986) 1.25
Detection and quantification of dysfunctional myocardium by magnetic resonance imaging. A new three-dimensional method for quantitative wall-thickening analysis. Circulation (1997) 1.22
Relation between infarct size and left ventricular performance assessed in patients with first acute myocardial infarction randomized to intracoronary thrombolytic therapy or to conventional treatment. Am J Cardiol (1988) 1.19
Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism. Circulation (1999) 1.19
Diagnosis of human coronary atherosclerosis by morphology-based Raman spectroscopy. Cardiovasc Pathol (2001) 1.18
Pulmonary artery root dilatation in Marfan syndrome: quantitative assessment of an unknown criterion. Heart (2002) 1.18
Intracardiac pseudotumor caused by mitral annular calcification. Eur J Echocardiogr (2005) 1.17
Clinical application of CT coronary angiography: state of the art. Heart Lung Circ (2010) 1.17
Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method. Circulation (1994) 1.17
8 October 1958, D Day for the implantable pacemaker. Neth Heart J (2008) 1.16
Assessment of myocardial damage in patients with acute myocardial infarction by serial measurement of serum alpha-hydroxybutyrate dehydrogenase levels. Am Heart J (1984) 1.16
Continuous stroke volume and cardiac output from intra-ventricular dimensions obtained with impedance catheter. Cardiovasc Res (1981) 1.16
I-123 labeled hexadecenoic acid in comparison with Thallium-201 for myocardial imaging in coronary heart disease. A preliminary study. Eur J Nucl Med (1980) 1.15
Quantitative assessment of dural ectasia as a marker for Marfan syndrome. Radiology (2001) 1.15
Imaging in cardiac resynchronisation therapy. Neth Heart J (2008) 1.15
Interaction of atherosclerosis and inflammation in elderly subjects with poor cognitive function. Neurology (2003) 1.15
Cyclic stretch induces the release of growth promoting factors from cultured neonatal cardiomyocytes and cardiac fibroblasts. Mol Cell Biochem (2000) 1.15
Cardiac first-pass and myocardial perfusion in normal subjects assessed by sub-second Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr (1991) 1.15